Efficacy of physical therapy for the treatment of lateral epicondylitis: a meta-analysis

Christoph Weber, Veronika Thai, Katrin Neuheuser, Katharina Groover, Oliver Christ, Christoph Weber, Veronika Thai, Katrin Neuheuser, Katharina Groover, Oliver Christ

Abstract

Background: Physical therapy for the treatment of lateral epicondylitis (LE) often comprises movement therapies, extracorporeal shockwave therapy (ECSWT), low level laser therapy (LLLT), low frequency electrical stimulation or pulsed electromagnetic fields. Still, only ECSWT and LLLT have been meta-analytically researched.

Methods: PUBMED, EMBASE and Cochrane database were systematically searched for randomized controlled trials (RCTs). Methodological quality of each study was rated with an adapted version of the Scottish Intercollegiate Guidelines Network (SIGN) checklist. Pain reduction (the difference between treatment and control groups at the end of trials) and pain relief (the change in pain from baseline to the end of trials) were calculated with mean differences (MD) and 95%-Confidence intervals (95 % CI).

Results: One thousand one hundred thirty eight studies were identified. One thousand seventy of those did not meet inclusion criteria. After full articles were retrieved 16 studies met inclusion criteria and 12 studies reported comparable outcome variables. Analyses were conducted for overall pain relief, pain relief during maximum handgrip strength tests, and maximum handgrip strength. There were not enough studies to conduct an analysis of physical function or other outcome variables.

Conclusions: Differences between treatment and control groups were larger than differences between treatments. Control group gains were 50 to 66% as high as treatment group gains. Still, only treatment groups with their combination of therapy specific and non-therapy specific factors reliably met criteria for clinical relevance. Results are discussed with respect to stability and their potential meaning for the use of non-therapy specific agents to optimize patients' gain.

Figures

Fig. 1
Fig. 1
Flow diagram of the article selection process
Fig. 2
Fig. 2
Overall pain relief in treatment groups
Fig. 3
Fig. 3
Overall pain relief in sham-groups
Fig. 4
Fig. 4
Overall pain relief in ECSWT groups
Fig. 5
Fig. 5
Overall pain relief in sham-ECSWT groups
Fig. 6
Fig. 6
Overall pain relief in Non-ECSWT treatment groups
Fig. 7
Fig. 7
Overall pain relief in Non-ECSWT sham-groups

References

    1. Shiri R, Viikari-Juntura E, Varonen H, Heliövaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006;164:1065–74. doi: 10.1093/aje/kwj325.
    1. Buchbinder R, Green S, Struijs P. Musculoskeletal disorders: tennis elbow. Clin Evid. 2008;05:1117–37.
    1. NGC-8513. Work Loss Data Institute . Elbow (acute & chronic) Encinitas (CA): Work Loss Data Institute; 2011.
    1. Rabago D, Best TM, Zgierska AE, Zeisig E, Ryan N, Crane D. A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma. Br J Sports Med. 2009;43:471–81. doi: 10.1136/bjsm.2008.052761.
    1. Krogh TP, Fredberg U, Stengaard-Pedersen K, Christensen R, Jensen P, Ellingsen T. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. Am J Sports Med. 2013;41(3):625–35. doi: 10.1177/0363546512472975.
    1. Shiple BJ. How effective are injection treatments for lateral epicondylitis? Clin J Sport Med. 2013;23(6):502–3. doi: 10.1097/JSM.0000000000000042.
    1. Bjordal JM, Lopes-Martins RAB, Joensen J, Couppe C, Ljunggren AE, Stergioulas A, Johnson MI. A systematic review with procedural assessments and meta-analysis of Low Level Laser Therapy in lateral elbow tendinopathy (tennis elbow) BMC Musculoskelet Disord. 2008;9:75. doi: 10.1186/1471-2474-9-75.
    1. Ho LOL, Kwong WL, Cheing GLY. Effectiveness of microcurrent therapy in the management of lateral epicondylitis: a pilot study. Hong Kong Physiother J. 2007;25:14–20. doi: 10.1016/S1013-7025(08)70004-6.
    1. Martinez-Silvestrini JA, Newcomer KL, Gay RE, Schaefer MP, Kortebein P, Arendt KW. Chronic lateral epicondylitis: comparative effectiveness of a home exercise program including stretching alone versus stretching supplemented with eccentric or concentric strengthening. J Hand Ther. 2005;18:411–20. doi: 10.1197/j.jht.2005.07.007.
    1. Peterson M, Butler S, Eriksson M, Svärdsudd K. A randomized controlled trial of exercise versus wait-list in chronic tennis elbow (lateral epicondylosis) Ups J Med Sci. 2011;116:269–79. doi: 10.3109/03009734.2011.600476.
    1. Basford JR, Sheffield CG, Cieslak KR. Laser therapy: a randomized, controlled trial of the effects of low intensity Nd: YAG laser irradiation on lateral epicondylitis. Arch Phys Med Rehabil. 2000;81:1504–10. doi: 10.1053/apmr.2000.17812.
    1. Bisset LM, Coppieters MW, Vicenzino B. Sensorimotor deficits remain despite resolution of symptoms using conservative treatment in patients with tennis elbow: a randomized controlled trial. Arch Phys Med Rehabil. 2009;90:1–8. doi: 10.1016/j.apmr.2008.06.031.
    1. Haake M, Böddeker IR, Decker T, Buch M, Vogel M, Labek G, Maier M, Loew M, Maier-Boerries O, Fischer J, Betthäuser A, Rehack HC, Kanovsky W, Müller I, Gerdesmeyer L, Rompe JD. Side-effects of extracorporeal shock wave therapy (ESWT) in the treatment of tennis elbow. Arch Orthop Trauma Surg. 2002;122:222–8. doi: 10.1007/s00402-001-0362-7.
    1. Lam LKY, Cheing GLY. Effects of 904 nm low-level laser therapy in the management of lateral epicondylitis: a randomised controlled trial. Photomed Laser Surg. 2007;25:65–71. doi: 10.1089/pho.2006.2047.
    1. Nourbakhsh MR, Fearon FJ. An alternative approach to treating lateral epicondylitis. A randomized, placebo-controlled, double-blinded study. Clin Rehabil. 2008;22:601–9. doi: 10.1177/0269215507088447.
    1. Pettrone FA, McCall BR. Extracorporeal shock wave therapy without local anesthesia for chronic lateral epicondylitis. J Bone Joint Surg. 2005;87:1297–304. doi: 10.2106/JBJS.C.01356.
    1. Rompe JD, Hopf C, Küllmer K, Heine J, Bürger R. Low-energy extracorporeal shock wave therapy for persistent tennis elbow. J Bone Joint Surg. 1996;78:233–7.
    1. Rompe JD, Riedel C, Betz U, Fink C. Chronic lateral epicondylitis of the elbow: a prospective study of low-energy shockwave therapy and low-energy shockwave therapy plus manual therapy of the cervical spine. Arch Phys Med Rehabil. 2001;82:578–82. doi: 10.1053/apmr.2001.22337.
    1. Rompe JD, Decking J, Schoelnner C, Theis C. Repetitive low-energy shock wave treatment for chronic lateral epicondylitis in tennis players. Am J Sports Med. 2004;32:734–43. doi: 10.1177/0363546503261697.
    1. Speed CA, Nichols D, Richards C, Humphreys H, Wies JT, Burnet S, Hazelman BL. Extracorporeal shock wave therapy for chronic lateral epicondylitis – a double blind randomised controlled trial. J Orthop Res. 2002;20:895–8. doi: 10.1016/S0736-0266(02)00013-X.
    1. Staples MP, Forbes A, Ptasznik R, Gordon J, Buchbinder R. A randomized controlled trial of extracorporeal shock wave therapy for lateral epicondylitis (Tennis Elbow) J Rheumatol. 2008;35:2038–46.
    1. Sterigioulas A. Effects of low-level laser and plyometric exercises in the treatment of lateral epicondylitis. Photomed Laser Surg. 2007;25:205–13. doi: 10.1089/pho.2007.2041.
    1. Uzunca K, Birtane M, Tastekin N. Effectiveness of pulsed electromagnetic field therapy in lateral epicondylitis. Clin Rheumatol. 2007;26:69–74. doi: 10.1007/s10067-006-0247-9.
    1. Wolf JM, Mountcastle S, Burks R, Sturdivant RX, Owens BD. Epidermiology of lateral and medial epicondylitis in a military population. Mil Med. 2010;175(5):336–9. doi: 10.7205/MILMED-D-09-00086.
    1. Chung B, Wiley JP. Effectiveness of extracorporeal shock wave therapy in the treatment of previously untreated lateral epicondylitis. Am J Sports Med. 2004;32:1660–7. doi: 10.1177/0363546503262806.
    1. Crowther MAA, Bannister GC, Huma H, Rooker GD. A prospective, randomized study to compare extracorporeal shock-wave therapy and injection of steroid for the treatment of tennis elbow. J Bone Joint Surg. 2002;84-B(5):678–9. doi: 10.1302/0301-620X.84B5.12741.
    1. Mehra A, Zaman T, Jenkin AIR. The use of a mobile lithotripter in the treatment of tennis elbow and plantar fasciitis. Surgeon. 2003;1(5):290–2. doi: 10.1016/S1479-666X(03)80048-3.
    1. Levitt RL, Selesnick H, Ogden J. Shockwave therapy for chronic lateral epicondylitis - an FDA study. San Francisco: Calif; 2004.
    1. Haker E, Lundeberg T. Laser treatment applied to acupuncture points in lateral humeral epicondylalgia. A double-blind study. Pain. 1990;43:243–7. doi: 10.1016/0304-3959(90)91078-W.
    1. Haker E, Lundeberg T. Lateral epicondylalgia: report of noneffective midlaser treatment. Arch Phys Med Rehabil. 1991;72:984–8.
    1. Krasheninnikoff M, Ellitsgaard N, Rogvi-Hansen B, Zeuthen A, Harder K, Larsen R, Gaardbo H. No effect of low power laser in lateral epicondylitis. Scand J Rheumatol. 1994;23:260–3. doi: 10.3109/03009749409103726.
    1. Lundeberg T, Haker E, Thomas M. Effect of laser versus placebo in tennis elbow. Scand J Rehab Med. 1987;19:135–8.
    1. Pallay RM, Seger W, Adler JL, Ettlinger RE, Quaidoo EA, Lipetz R, et al. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a three month, randomized, controlled trial. Scand J Rheumatol. 2004;33:257–66. doi: 10.1080/03009740410005728.
    1. Papadopoulos ES, Smith RW, Cawley MID, Mani R. Low-level laser therapy does not aid the management of tennis elbow. Clin Rehabil. 1996;10:9–11. doi: 10.1177/026921559601000103.
    1. Vasseljen O, Høeg N, Kjeldstad B, Johnsson A, Larsen S. Low level laser versus placebo in the treatment of tennis elbow. Scand J Rehab Med. 1992;24:37–42.
    1. Benedetti F, Mayberg HS, Wagner TD, Stohler CS, Zubieta J-K. Neurobiological mechanisms of the placebo-effect. J Neurosci. 2005;25:10390–402. doi: 10.1523/JNEUROSCI.3458-05.2005.
    1. Farrar JT, Young JP, Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149–58. doi: 10.1016/S0304-3959(01)00349-9.
    1. Altman RD, Zinsenheim JR, Temple AR, Schweinle JR. Three-month efficacy and safety of acetaminophen extended-release for osteoarthritis pain of the hip or knee: a randomized, double-blind, placebo-controlled study. Osteoarthitis Cartilage. 2007;15:454–61. doi: 10.1016/j.joca.2006.10.008.
    1. Babul ND, Novek R, Chipman H, Roth SH, Gana T, Albert K. Efficacy and safety of extended-release, once-daily trmadol in chronic pain: a randomized 12-Week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage. 2004;28(1):59–71. doi: 10.1016/j.jpainsymman.2003.11.006.
    1. Gana TJ, Pascual ML, Fleming RR, Schein JR, Janagap CC, Xiang J. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin. 2006;22(7):1391–401. doi: 10.1185/030079906X115595.
    1. Gibofsky A, Williams GW, McMenna F, Fort JG. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis. Arthritis Rheum. 2003;48(11):3102–11. doi: 10.1002/art.11330.
    1. Grifka JK, Zacher J, Brown JP, Seriolo B, Lee A, Moorem A, et al. Efficacy and tolerability of lumiracoxib versus placebo in patients with osteoarthritis of the hand. Clin Exp Rheumatol. 2004;22:589–96.
    1. Leung AT, Malmstrom K, Gallacher AE, Sarembock B, Poor G, Beaulieu A, et al. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: a 13-week randomized, double-blind, placebo and active- comparator controlled 12-week efficacy trial. Curr Med Res Opin. 2002;18(2):49–58. doi: 10.1185/030079902125000282.
    1. Schnitzer TJ, Gray WL, Paster RZ, Kamin M. Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol. 2000;27:772–8.
    1. Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. JAMA. 1999;282(20):1921–8. doi: 10.1001/jama.282.20.1921.
    1. Tannenbaum H, Berenbaum F, Reginster JY, Zacher J, Robinson J, Poor G, et al. Lumiracoxib is effective in the treatment of osteoarthitis oft the knee: a 13 week, randomized, double blind study versus placebo and celecoxib – osteoarthritis-pain-intensity-scale. Ann Rheum Dis. 2004;63:1419–26. doi: 10.1136/ard.2003.015974.
    1. Öken Ö, Kahraman Y, Ayhan F, Canpolat S, Yorgancioglu ZR. The short-term efficacy of laser, brace, and ultrasound treatment in lateral epicondylitis: a prospective, randomized. Controlled Trial J Hand Ther. 2008;21:63–7. doi: 10.1197/j.jht.2007.09.003.

Source: PubMed

3
Prenumerera